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ABSTRACT
Background: L-Carnitine is the essential endogenous factor for the trans-
port of long-chain fatty acids from the cytoplasm to within the mitochondrion
where the β-oxidation process takes place. L-Carnitine is a superoxide scavenger
and an antioxidant that possesses an anti-ischemic action and a stabilizing effect
on cell membranes. It may be of help in liver ischemia reperfusion injury. Re-
sults regarding the effects of L-carnitine on liver ischemia and reperfusion injury
are few and conflicting. 
Objective: The aim of this study was to investigate the efficacy of exogenous
L-carnitine on lipid peroxidation and protecting liver at different stages of experi-
mental total warm hepatic ischemia-reperfusion (TWHIR) procedure in rats.
Methods: This experimental study in healthy, weanling, male Wistar rats
(weighing 180–200 g) was conducted at the Experimental Animal Research
Laboratory of the Faculty of Medicine of Mersin University, Mersin, Turkey. Rats
were randomly divided into 5 groups: (A) Control group; (B) TWHIR procedure
only; (C) L-carnitine administered 2 hours before the TWHIR procedure; (D) 
L-carnitine administered just before the TWHIR procedure; and (E) L-carnitine
administered after total warm hepatic ischemia but just before the reperfusion
procedure. Total warm hepatic ischemia (via the Pringle maneuver) and reperfu-
sion were performed for 45 and 30 minutes, respectively. L-Carnitine (200 mg/kg)
was administered intravenously. At the end of each procedure a blood sample
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was drawn and total hepatectomy was performed following reperfusion.
Malondialdehyde (MDA) and myeloperoxidase (MPO) levels of both plasma and
liver tissue, total antioxidant capacity (TAOC), alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) levels in plasma, and histopathologic examina-
tion were analyzed to assess lipid peroxidation and damage in liver tissue.
Results: Thirty-four rats (mean [SD] age, 59.26 [1.2] days; mean [SD] weight,
194.1 [5.1] g) were used in the study. There was a significant difference observed
between groups A (n = 5) and B (n = 5) for all evaluation parameters. The TWHIR
procedure performed in group B was associated with significant increases ver-
sus baseline in ALT, AST, MDA, and MPO in plasma, and MDA and MPO in liver
tissue, but a significant decrease of TAOC in plasma. ALT, AST, serum and liver
MDA, and MPO levels of group B were significantly higher than all groups
administered L-carnitine. L-Carnitine administration between total warm hepatic
ischemia and reperfusion was associated with a significant attenuation in all
parameters. The liver MDA levels of groups C (n = 8) and D (n = 8) were signifi-
cantly lower than that of group E (n = 8) (mean [SD]: C, 16.53 [3.32] and D, 18.28
[1.67] vs E, 23.05 [3.52]; P = 0.001 and P = 0.016, respectively). The mean (SD)
liver MPO level of group C (1.09 [0.16]) was significantly lower than that of
groups D (2.12 [0.25]) and E (2.11 [0.28]) (both, P = 0.001). The TAOC of group
B (0.77 [0.12]) was significantly lower than that of groups C (1.34 [0.19]) and D
(1.08 [0.20]) (P = 0.001 and P = 0.015, respectively). The TAOC of group C was
significantly higher than that of the other L-carnitine groups (E, 0.94 [0.13]) (P =
0.023 vs group D; and P = 0.001 vs group E). Histopathologic scores of groups A,
C, and E were significantly lower than that of group B, but the difference
between groups B and D was not statistically significant.
Conclusions: In this experimental study, administration of exogenous 
L-carnitine was associated with significantly decreased lipid peroxidation in
plasma and liver tissue when administered prior to a TWHIR procedure. In
addition, L-carnitine seemed to be more effective with regard to decreasing
lipid peroxidation in liver tissue when administered before warm hepatic
ischemia. L-Carnitine was associated with significantly decreased leukocyte
sequestration in plasma and liver tissue. A significant increase in TAOC was
associated with L-carnitine administered prior to ischemia. These observa-
tions suggest that L-carnitine might have a protective effect against
ischemia-reperfusion injury in rat liver tissue. (Curr Ther Res Clin Exp. 2007;
68:32–46) Copyright © 2007 Excerpta Medica, Inc.
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INTRODUCTION
Ischemia-reperfusion (IR) injury is a phenomenon whereby cellular damage in
a hypoxic organ is accentuated following the restoration of oxygen delivery.1
Injury associated with total warm hepatic ischemia reperfusion (TWHIR) is 
relevant clinically with regard to hepatic surgery, liver transplantation, hypo-
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volemic shock, types of toxic liver injury, veno-occlusive disease, and Budd–
Chiari syndrome.
Reperfusion of ischemic tissue is believed to cause cellular damage through
the production of free oxygen radicals.2 One of the most popular hypotheses to
explain injury by reactive oxygen species is the damage of membranes by lipid
peroxidation.3
There is a need to increase the ischemic time period without damaging the
liver when performing major hepatic surgery and liver transplantation. Among
the currently tested therapeutic strategies, ischemic preconditioning or phar-
macologic interventions that prevent the formation of reactive oxygen species
and/or promote their detoxification have the greatest potential to eliminate the
postischemic oxidant stress and reduce IR injury.3 L-Carnitine is one agent being
tested for the prevention of liver damage induced by IR.4–6
L-Carnitine is the essential endogenous factor for the transport of long-chain
fatty acids (acyl-CoA) from the cytoplasm to within the mitochondrion where
the β-oxidation process takes place. It increases the oxidation of glucose during
the reperfusion phase by performing transportation of long-chain fatty acids to
the mitochondrial matrix for β-oxidation.7 L-Carnitine is a superoxide scavenger,
antioxidant, and DNA cleavage protector.8 It also has an anti-ischemic action and
a stabilizing effect on cell membranes.2
L-Carnitine has been studied in experimental IR injury models regarding the
heart, kidney, skeletal muscle, spinal cord, and skin flaps. Experimental studies
in animals concerning the heart have suggested that L-carnitine possesses an
anti-ischemic action.2 L-Carnitine has been found to be of value for preventing
decline in renal function that occurs during IR.9 It has been reported as effec-
tive for reducing the IR injury in skeletal muscle7 and has also been found to
protect the motor neuron cells from ischemic spinal cord injury.10 L-Carnitine
has a dose-dependent effect to increase flap survival in random skin flaps.11 A
literature search was performed utilizing Entrez PubMed (no time or language
limits; key terms: total warm hepatic ischemia reperfusion, carnitine, and human).
Despite the existence of several experimental studies, there appear to be no
well-designed human studies of L-carnitine treatment administered for TWHIR
injury; this is a limitation of the available literature. 
There are few studies regarding the effect of exogenous L-carnitine on liver IR
injury. A trial by Yonezawa et al4 could not demonstrate a protective effect of 
L-carnitine to warm hepatic IR injury. But the study by Atila et al5 found that
exogenous L-carnitine might be helpful in preventing free oxygen radical damage
and inflammatory reactions in liver tissue related to warm hepatic IR. Puetz et al6
found that L-carnitine might be suitable to protect fatty livers from IR injury.
The aim of our study was to investigate the efficacy of exogenous L-carnitine
on lipid peroxidation and liver damage when administered at different stages of
experimental TWHIR procedure in rats. We expect this study to supply more
evidence to the existing literature about the effects of L-carnitine by using
myeloperoxidase (MPO) and total antioxidant capacity (TAOC) in addition to
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malondialdehyde (MDA) to evaluate the damage in liver tissue. This study
might also help determine the timing of L-carnitine administration to provide
better results in decreasing lipid peroxidation and liver damage.
MATERIALS AND METHODS
After study design approval from the institutional ethical committee, 34 healthy,
weanling, male Wistar rats weighing 180 to 200 g were obtained from the experi-
mental animal producing center of the institution (Mersin University, Mersin,
Turkey). Study animals were kept in standard cages and had access to water
and rat chow ad libitum. All experiments were carried out in accordance with
the guidelines of the National Animal Welfare Law12 and with the Helsinki
Declaration of Animal Rights.13
Study Design
Rats were randomly divided into 5 groups: (A) control group; (B) TWHIR
procedure only; (C) L-carnitine administered 2 hours before the TWHIR 
procedure; (D) L-carnitine administered just before the TWHIR procedure;
and (E) L-carnitine administered after total warm hepatic ischemia but just
before the reperfusion procedure. Before surgical procedures, all rats were
anesthetized with ketamine 100 mg/kg intramuscularly. After laparotomy,
total liver ischemia was achieved by clamping the hepatic pedicle (Pringle
maneuver) with a microvascular clamp for 45 minutes. Reperfusion was per-
formed by removing the clamps for 30 minutes. IV L-carnitine 200 mg/kg was
administered to rats in groups D and E over 1 minute through infrahepatic
vena cava during laparotomy. In group C, L-carnitine was administered through
the tail vein of the rats before laparotomy. At the end of the reperfusion
period, blood samples were drawn from the suprahepatic vena cava by a fine
needle. A total hepatectomy was performed before the rats were euthanized.
Each liver tissue sample was divided into 2 pieces of equal size for histopatho-
logic and biochemical evaluations. The rats in group A (control) received
hepatic pedicle preparation but no clamping. Alanine aminotransferase (ALT)
and aspartate aminotransferase (AST) levels, TAOC of plasma, and MDA and
MPO levels of both plasma and liver tissue were studied to evaluate the dam-
age in liver tissue.
The comparison of group A with group B was made to determine if TWHIR
caused an injury in the liver tissue. Group B was compared with groups C, D,
and E to determine whether L-carnitine decreased liver tissue damage or not.
Groups C, D, and E were also compared with each other to evaluate at which
stage of the TWHIR procedure L-carnitine was most effective.
Plasma and Liver Tissue Analyses
Blood taken from the rats was centrifuged for 5 minutes at 3000 rpm and the
plasma obtained was stored at –20°C until analysis.
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Plasma ALT and AST
ALT and AST levels of plasma were analyzed using a Cobas Integra 700 bio-
chemical analyzer (Roche Diagnostics, GmbH, Mannheim, Germany).
MDA in Plasma and Liver Tissue
Liver tissues were homogenized in 0.15% potassium chloride and then cen-
trifuged for 10 minutes at 300 rpm. Liver tissue supernatant and plasma MDA
levels, as an index of lipid peroxidation, were determined by thiobarbituric acid
reaction according to the procedures used by Yagi.14 The principle of MDA
determination in plasma and tissue homogenates depends on measurement of
the color produced by the interaction of barbituric acid with MDA as a result of
lipid peroxidation. The color-reactive 1,1,3,3-tetraethoxypropane was used as
the primary standard.
MPO in Serum and Liver Tissue
MPO is a heme-containing enzyme within the azurophil granules of neutrophils,
and MPO activity was measured as a simple quantitative method of detecting
leukosequestration. A 300-mg tissue sample was homogenized in 0.02 M ethylene-
diaminetetraacetic acid (pH = 4.7) in a Teflon Potter homogenizer (Braun,
Melsungen, Germany). Homogenates were centrifuged at 20,000g for 15 minutes
at 4°C. Afterward, the pellet was rehomogenized in 1.5 mL 0.5% hexadecyl-
trimethylammonium and centrifuged at 20,000g for 15 minutes at 4°C. The princi-
ple of MPO determination in plasma and tissue homogenates depends on the
fact that it reduces o-dianisidine. The o-dianisidine was measured at 410 nm by
spectrophotometer (Cary 1, Varian Australia Pty Ltd, Clayton South, Australia).15
Total Antioxidant Status
ABTS (2,2′-Azino-di-[3-ethylbenzthiazolinesulfonate]) is incubated with a per-
oxidase (methemoglobin) and hydrogen peroxide to produce the radical cation
ABTS+. This has a relatively stable blue-green color, which is measured at 600 nm.
Antioxidants in the added sample cause suppression of this color production to
a degree, that is proportional to their concentration.16
Histopathologic Examination
The liver tissues were fixed in a 10% formalin solution for 24 hours. Standard
dehydration was then performed and the samples were embedded in paraffin
wax. Hematoxylin and eosin (H-E) stained slides were prepared by using stan-
dard methods.17 Light microscopic analysis of the liver tissues was performed
by a researcher (C.T.) blinded to allocation group. H-E stained slides were inves-
tigated at 40, 100, and 200 magnifications.
Portal and lobular inflammations were scored between 0 and 3. The scoring
system of histopathologic changes was: 0 = no inflammatory cells in portal or
lobular space, and no hepatocyte necrosis; 1 = minimal focal inflammation or
hepatocyte necrosis in portal or lobular space; 2 = moderate focal inflammation
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or hepatocyte necrosis in portal or lobular space; and 3 = severe focal inflam-
mation or hepatocyte necrosis in portal or lobular space.5
Statistical Analyses
The differences between the 5 groups were determined using analysis of vari-
ance. The comparison of the L-carnitine groups (C–E) with the TWHIR-only
group (B) was performed by Dunnett’s test. Comparison between groups C,
D, and E was performed by Tukey test. ALT and AST were analyzed with a non-
parametric test, the Kruskal-Wallis test. The Dunn multiple comparison test was
used to compare histopathologic scoring.
Data for ALT and AST were presented as median with 25th to 75th per-
centiles, as a descriptive statistic; for other parameters mean (SD) were deter-
mined, and 95% CI values were reported in the figures. A value of P < 0.05 was
considered statistically significant. All statistical analyses were performed with
SPSS version 11.5 (SPSS Inc., Chicago, Illinois).
RESULTS
Thirty-four rats (mean [SD] age, 59.26 [1.2] days; mean [SD] weight, 194.1 [5.1] g)
were randomly divided into 1 of 5 groups. The values of evaluation parameters
in group A (n = 5) represented the baseline values of rats. The values in group
B (n = 5) presented the results of rats injured after hepatic ischemia and reper-
fusion procedure. The values obtained in groups C (n = 8), D (n = 8), and E (n = 8)
reflected the effect of exogenous L-carnitine at different stages of the ischemia
and reperfusion procedure.
Plasma ALT and AST
Median plasma ALT levels with 25th to 75th percentiles were the following: A,
31 (31–33); B, 345 (204–574); C, 146 (139–170); D, 178 (157–221); and E, 161
(147–177). Median plasma AST levels with 25th to 75th percentiles were the fol-
lowing: A, 21 (17–69); B, 468 (288–586); C, 121 (107–140); D, 186 (162–232); and
E, 172 (161–249). Plasma ALT and AST levels of group B were significantly higher
than those of group A (P = 0.020 and P = 0.001, respectively).
The descriptive statistics of plasma ALT and AST for the TWHIR groups (B–E)
are shown in Figure 1. L-Carnitine administered in groups C, D, and E was asso-
ciated with a reduction in plasma ALT and AST levels when compared with
group B (P = 0.001 for all comparisons). There was not a significant difference
between the L-carnitine groups for comparison of plasma ALT and AST.
MDA and MPO of Plasma and Liver Tissue
Mean (SD) nmol/mL of plasma MDA were as follows: A, 3.66 (2.44); B, 20.04
(9.66); C, 9.65 (3.31); D, 10.17 (1.94); and E, 7.94 (2.24). Mean (SD) nmol/g of liver
tissue MDA were: A, 9.75 (4.90); B, 30.47 (3.61); C, 16.53 (3.32); D, 18.28 (1.67);
and E, 23.05 (3.52). Plasma and liver tissue MDA levels of group B were signifi-
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cantly higher than group A (P = 0.017 and P = 0.001, respectively). The descrip-
tive statistics of both plasma and liver tissue MDA for TWHIR groups are shown
in Figure 2A. Significantly lower levels of plasma MDA were observed in the 
L-carnitine groups (C, D, and E) when compared with group B (P = 0.001 for each
comparison). The difference in plasma MDA levels between the L-carnitine
groups was not statistically significant. Liver MDA generation in the L-carnitine
groups was significantly lower than that observed in group B (P = 0.001 for all
comparisons). When the L-carnitine groups were compared with each other,
liver MDA generation in groups C and D were significantly lower than group E
(P = 0.001 and P = 0.016, respectively).
Mean (SD) U/L of plasma MPO activity were as follows: A, 0.27 (0.04); 
B, 1.22 (0.10); C, 0.80 (0.22); D, 0.83 (0.37); and E, 0.59 (0.16). Mean (SD) U/g
of liver tissue MPO activity were as follows: A, 0.92 (0.13); B, 2.65 (0.23); C, 1.09
(0.16); D, 2.12 (0.25); and E, 2.11 (0.28). Plasma and liver tissue MPO activity
levels of group B were significantly higher than group A (P = 0.001 and P =
0.001, respectively). The descriptive statistics of both plasma and liver tissue
MPO activity for the groups that underwent TWHIR are shown in Figure 2B.
Plasma MPO activity for the groups administered L-carnitine (C, D, and E)
was significantly lower than for group B (P = 0.016, P = 0.022, and P = 0.001,
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Figure 1. Median aspartate aminotransferase (AST) and alanine aminotransferase
(ALT) values with the 25% to 75% interval in the 5 study groups (A–E). (A)
Control (n = 5); (B) total warm hepatic ischemia-reperfusion (TWHIR) pro-
cedure only (n = 5); (C) L-carnitine administered 2 hours before the TWHIR
procedure (n = 8); (D) L-carnitine administered just before the TWHIR pro-
cedure (n = 8); and (E) L-carnitine administered after total warm hepatic
ischemia but just before the reperfusion procedure (n = 8). *P = 0.020
versus group A; †P = 0.001 versus group A; ‡P = 0.001 versus group B.
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respectively). However, there was not a significant difference between the 
L-carnitine groups with regard to plasma MPO activity level. Liver tissue MPO
activity for all of the L-carnitine groups was significantly lower than for group
B (all, P = 0.001). When these groups were compared with each other, liver
tissue MPO activity in group C was significantly lower than groups D and E
(both, P = 0.001).
Total Antioxidant Status
Mean (SD) mmol/L of plasma TAOC were as follows: A, 1.94 (0.21); B, 0.77
(0.12); C, 1.34 (0.19); D, 1.08 (0.20); and E, 0.94 (0.13). TAOC of group B was sig-
nificantly decreased when compared with group A (P = 0.001). The descriptive
statistics of TAOC for groups B through E are shown in Figure 3. Administration of
L-carnitine in groups C and D was associated with significantly increased TAOC
when compared with group B (P = 0.001 and P = 0.015, respectively). When the
groups administered L-carnitine were compared with each other, the TAOC of
group C was significantly higher than those of groups D and E (P = 0.023 and 
P = 0.001, respectively).
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Figure 2A. Malondialdehyde (95% CI) values of both serum and liver tissue in the 5 study
groups (A–E). (A) Control (n = 5); (B) total warm hepatic ischemia-reperfusion
(TWHIR) procedure only (n = 5); (C) L-carnitine administered 2 hours before
the TWHIR procedure (n = 8); (D) L-carnitine administered just before the
TWHIR procedure (n = 8); and (E) L-carnitine administered after total warm
hepatic ischemia but just before the reperfusion procedure (n = 8). *P =
0.017 versus group A; †P = 0.001 versus group A; ‡P = 0.001 versus group B;
§P = 0.001 versus group C; P = 0.016 versus group D.
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Histopathologic Scoring
Normal histologic findings were detected after the histopathologic examina-
tion of the liver tissue of the rats in the control group (median [25%–75% inter-
val], 0 [0–0.5]). Severe focal inflammation or hepatocyte necrosis was observed
in the portal or lobular space besides reactive Kupffer cells as were fibrin
deposits in the sinusoids of group B rats (3.0 [2.0–3.0]). Minimal focal inflamma-
tion or hepatocyte necrosis in the portal or lobular space was detected in all 3
carnitine groups. Median score and 25% to 75% interval range for groups C, D,
and E were as follows: 1.0 (1.0–1.0), 1.5 (1.0–2.0),  and 1.0 (1.0–1.7), respectively.
The median score of group B was significantly higher than that of the con-
trol group (P = 0.008), indicating damage caused by the TWHIR procedure. The
median score of groups C and E were significantly lower than that of group B
(P = 0.012 and P = 0.036, respectively). This suggests that L-carnitine adminis-
tration reduced inflammation and hepatocyte necrosis. Although the median
score of group D was lower than group B, the difference was not statistically
significant. The comparison of carnitine groups with each other revealed no
statistical significance.
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Figure 2B. Myeloperoxidase (95% CI) values of both serum and liver tissue in the 
5 study groups (A–E). (A) Control (n = 5); (B) total warm hepatic ischemia-
reperfusion (TWHIR) procedure only (n = 5); (C) L-carnitine administered 
2 hours before the TWHIR procedure (n = 8); (D) L-carnitine administered
just before the TWHIR procedure (n = 8); and (E) L-carnitine administered
after total warm hepatic ischemia but just before the reperfusion procedure
(n = 8). *P = 0.001 versus group A; †P = 0.016 versus group C; ‡P = 0.022 ver-
sus group D; §P = 0.010 versus group E; P = 0.001 versus group B; ¶P = 0.001
versus group C.
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DISCUSSION
Operative blood loss has been recognized as the main factor associated with
morbidity and mortality in liver resections. Occlusion of the hepatic inflow by
clamping of the hepatic pedicle is the oldest method to reduce bleeding from a
cut or torn liver tissue. Pringle first used it in patients with liver trauma and
reported it with the results of his experimental observations.18 The normal liver
can tolerate continuous pedicular clamping for up to 60 minutes. The Pringle
maneuver is a useful technique employed in controlling bleeding during the
repair of extensive liver wounds, and when performing hepatic resection and
liver transplantation. However, if the period of clamping the hepatic vasculature
is too long, TWHIR injury may result.1 Therefore, a need is evident to increase
the ischemic time period to perform more complicated hepatic surgery without
damaging the liver.
There are 2 distinct phases of liver injury after TWHIR.19 The initial phase (<2 h
after reperfusion) is characterized by oxidant stress, where production and
release of reactive oxygen species appears to directly result in hepatocellular
injury.1 One of the most popular hypotheses to explain injury by reactive oxy-
gen species is the damage of membranes by lipid peroxidation. This mechanism
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Figure 3. Total antioxidant capacity (TAOC) values (95% CI) for all 5 study groups
(A–E). (A) Control (n = 5); (B) total warm hepatic ischemia-reperfusion
(TWHIR) procedure only (n = 5); (C) L-carnitine administered 2 hours
before the TWHIR procedure (n = 8); (D) L-carnitine administered just
before the TWHIR procedure (n = 8); and (E) L-carnitine administered after
total warm hepatic ischemia but just before the reperfusion procedure 
(n = 8). *P = 0.001 versus group A; †P = 0.001 versus group C; ‡P = 0.015
versus group D; §P = 0.023 versus group D; P = 0.001 versus group E.
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could certainly explain a loss of ion homeostasis, cell swelling, and necrotic cell
death, which are prominent features of reperfusion injury.3 Endogenous anti-
oxidants usually limit damage by free oxygen radicals; however, studies on
models of hepatic IR have suggested that their levels fall during the reperfusion
period.20,21 This is probably the result of degradation of the antioxidants due to
the increased free radical activity.22 Many antioxidant interventions (eg, allop-
urinol, vitamin E, glutathione, superoxide dismutase, catalase) have been asso-
ciated with reduced lipid peroxidation and reperfusion injury.23
The Pringle maneuver was used in the present experimental study to per-
form total warm hepatic ischemia. Because of its antioxidant and free oxygen
radical scavenger effects, exogenous L-carnitine was used in this study. The
same time periods of total warm ischemia and reperfusion were used by
Kobayashi et al24 to maintain liver damage in rats. As the initial (early) phase of
liver IR injury was defined as the time period <2 hours after reperfusion,1 the
results of this study reflected the early phase of hepatic injury. Hepatic IR
injury, if severe enough, may result in pericentral liver hypoxia, which leads to
ischemic hepatitis, characterized by a dramatic rise in serum aminotransferase
in the absence of other causes of hepatic necrosis.1 Significantly higher levels
of ALT and AST in group B when compared with group A suggested that our
experimental model of TWHIR injury caused liver damage. The decrease in
serum aminotransferases in all 3 groups administered L-carnitine indicated
attenuation of the liver damage. This effect of L-carnitine was observed when
administered at any stage of TWHIR procedure. Although the methods and
dosage of carnitine administered were different, Atila et al5 and Puetz et al6
reached similar results.
It is understood that oxygen-free radicals are associated with tissue damage
that occurs on reperfusion after an ischemic period.25 Reactive oxygen species
damage the cell membranes by lipid peroxidation. Lipid peroxidation products
may also be involved in the amplification and continuation of the inflammatory
response.3 Lipid peroxidation process has been found to cause liver cell damage
during IR.26 The MDA is a result of lipid peroxidation. The concentration of free
oxygen radicals is usually estimated in connection with the production of MDA.27
In our study, a significantly higher level of MDA both in serum and liver tissue in
group B suggested that TWHIR was the cause of lipid peroxidation. In accordance
with the results of the present study, there was an increase of plasma and liver
MDA concentrations observed in the study by Su et al.28 The decrease in concen-
trations of both plasma and liver MDA in groups C, D, and E suggested that
exogenous L-carnitine administration maintained an attenuation in MDA levels
(Figure 2). This effect of L-carnitine in this study is thought to be associated with
the cell membrane stabilizing ability, which accounts for its anti-ischemic action,2
and superoxide scavenger and antioxidant effects.8 On the other hand, the study
by Yonezawa et al4 used partial hepatic ischemia and demonstrated that carnitine
did not significantly decrease lipid peroxidation. Although different in method, the
effect of L-carnitine for preventing lipid peroxidation in experimental acute hepatic
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damage induced by carbon tetrachloride29 and valproic acid28 was similar to the
present study. In these 2 experiments, liver damage was induced by a method
other than ischemia.
In the present study, administration of L-carnitine at different time periods of
the ischemia-reperfusion procedure did not make a difference in plasma MDA
levels. However, L-carnitine administered before ischemia (groups C and D) was
significantly more effective for decreasing lipid peroxidation in the liver tissue
(Figure 2) than when it was administered after ischemia (group E). This may be
associated with the limited efficacy of L-carnitine during acute emergency situ-
ations following an ischemic episode.2
Polymorphonuclear leukocytes may preferentially accumulate in the endothe-
lium during ischemia, and such accumulation may be markedly accelerated fol-
lowing reperfusion. Subsequently, polymorphonuclear leukocytes infiltrate the
ischemic lesions and cause damage.30 The activation of complementary and gen-
eration of primary cytokines and chemokines during reperfusion are responsible
for the recruitment of neutrophils into the liver. A neutrophil-derived oxidant
stress is important in the pathophysiology of reperfusion injury in the liver.3 The
study by Vollmar et al31 demonstrated that there was a leukocyte flux to liver
after hepatic IR. MPO activity is used as a simple quantitative method of detect-
ing leukosequestration.15 The significantly high MPO activity of both serum and
liver tissue in group B demonstrated that IR caused an increase of leukocyte
flux. Concordant with the results of the present study, Liu et al26 found that
MPO activity in liver tissue was high in an experimental hepatic IR model
reflecting polymorphonuclear leukocyte infiltration after reperfusion. The
increase of hepatic leukocyte flux after ischemia reperfusion may be the result
of both the manifestation of a systemic inflammatory response and the increase
of local chemoattractant activities, such as the production and release of the
cytokine-induced neutrophil chemoattractant of the interleukin-8 family.31 The
low MPO activities in carnitine groups reflected the attenuation of leukocyte
accumulation both in plasma and liver tissue. There was not a difference
between the L-carnitine groups with regard to decreasing plasma MPO activity.
However, L-carnitine administered 2 hours before ischemia was observed to be
significantly more effective in decreasing leukocyte accumulation in the liver
tissue (Figure 2). To our knowledge there is no other study that has used MPO
activity to evaluate the effects of L-carnitine in hepatic ischemia and reperfu-
sion procedure. However, the study by Gorur et al32 found that L-carnitine was
associated with decreased inflammation and neutrophil infiltration in kidney
tissue in a rat kidney IR injury model, which supports the findings of the pres-
ent study.
TAOC of body fluids expresses a cooperative interaction between various
antioxidants and is crucial for the maximum suppression of a free radical reac-
tion in extracellular compartments.33 TAOC was significantly decreased during
hepatic IR in the present study. In accordance with the present study, TAOC was
decreased after hepatic IR in an experimental study by Su et al.28 The adminis-
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tration of L-carnitine was associated with increased TAOC in the present study.
However, the increase of TAOC was not significant in group E when compared
with group B. L-Carnitine administered after ischemia (group E) was not associ-
ated with a significant increase in TAOC. The greatest increase in TAOC was
associated with administration of L-carnitine 2 hours before ischemia (Figure 3).
To our knowledge, no other study has compared TAOC while evaluating the
effect of L-carnitine in hepatic IR; but there is an agreement between the results
of the present study and a study of valproic acid-induced liver damage in which
L-carnitine was associated with increased TAOC.34 The effect of L-carnitine to
increase TAOC is related to its antioxidant effect, which is a result of the scav-
enging capacity of reactive oxygen species.8 In our study, L-carnitine adminis-
tered after hepatic ischemia (group E) did not increase TAOC significantly.
Again, this may be associated with the limited efficacy of L-carnitine during
acute emergency situations after an ischemic episode.2
When the histopathologic changes were taken into consideration, there was
accordance with the findings of Atila et al5 and the present study; carnitine was
associated with a protective effect in liver tissue. Liver tissue appeared normal
in the control group and damaged in the group that received only the TWHIR
procedure (group B). This damage was characterized by severe inflammatory
changes in lobular and portal spaces, and hepatocyte necrosis. There was an
improvement in the histopathologic scores of the L-carnitine groups, reflecting
an attenuation of liver tissue damage. Also, the result of histopathologic scor-
ing was compatible with the improved results of all other biochemical evalua-
tion parameters obtained after administration of carnitine.
Study Limitations
The administration of carnitine through the tail vein in group C was a limita-
tion of this study design. However, this alternate route of administration was
preferred to standardize the time period of procedure starting with laparotomy
and finishing at the end of reperfusion, and prevent repeated administration
and greater amount of anesthetic agent. The small number of rats in each arm
of the study made the interpretation of histopathologic results difficult.
CONCLUSIONS
In this experimental study, administration of exogenous L-carnitine was associ-
ated with significantly decreased lipid peroxidation in plasma and liver tissue
when administered prior to a TWHIR procedure. In addition, L-carnitine seemed
to be more effective with regard to decreasing lipid peroxidation in liver tissue
when administered before warm hepatic ischemia. L-Carnitine was associated
with significantly decreased leukocyte sequestration in plasma and liver tissue.
A significant increase in TAOC was associated with L-carnitine administered
prior to ischemia. These observations suggest that L-carnitine might have a pro-
tective effect against IR injury in rat liver tissue.
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